Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments

Summary: Host: Scott Kahan, MD, MPH <br> Guest: Ken Fujioka, MD <br> Guest: Carol Wysham, MD <br> <p><span xml:lang="EN-US" data-contrast="none">Embark on a transformative journey to redefine patient care for individuals with type 2 diabetes by transitioning from the conventional focus on glycemic control to a pioneering obesity-centered approach. Immerse yourself in the expertise of 3 distinguished professionals: Drs. Carol Wysham, Scott Kahan, and Ken Fujioka. These esteemed experts will guide you through the dynamic terrain of weight loss medications, including GLP-1/GIP dual receptor agonists, and provide invaluable insights to elevate and optimize patient outcomes in the realm of type 2 diabetes management. </span> </p>